AstraZeneca Pharma India today reported a standalone net profit of Rs 2.71 crore for the first quarter ended June 30, 2015.
The company had posted a net loss of Rs 17.60 crore in the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.
Standalone total income from operations of the company also rose to Rs 131.97 crore during the quarter under consideration as against Rs 125.64 crore for the same period, a year ago.
No comments:
Post a Comment